Kounis syndrome associated with BNT162b2 mRNA COVID-19 vaccine presenting as ST-elevation acute myocardial infarction.

Sanci, Emre; Örçen, Cihan; Çelik, Osman Muhsin; Özen, Muhammed Tahsin; Bozyel, Serdar

Sanci, Emre; Örçen, Cihan; Çelik, Osman Muhsin; Özen, Muhammed Tahsin; Bozyel, Serdar.

Afiliación

Sanci E; Departments of Emergency Medicine, and Kocaeli Derince Training and Research Hospital; Kocaeli-Turkey.
Örçen C; Departments of Allergy and Immunology, Kocaeli Derince Training and Research Hospital; Kocaeli-Turkey.
Çelik OM; Departments of Cardiology, Kocaeli Derince Training and Research Hospital; Kocaeli-Turkey.
Özen MT; Departments of Emergency Medicine, and Kocaeli Derince Training and Research Hospital; Kocaeli-Turkey.
Bozyel S; Departments of Cardiology, Kocaeli Derince Training and Research Hospital; Kocaeli-Turkey.

Anatol J Cardiol ; 26(1): 69-74, 2022 01.

Article en En | MEDLINE | ID: mdl-35191390

Asunto(s)

COVID-19; Síndrome de Kounis; Infarto del Miocardio con Elevación del ST; Vacuna BNT162; Vacunas contra la COVID-19; Humanos; Síndrome de Kounis/genética; ARN Mensajero; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infarto del Miocardio con Elevación del ST / Síndrome de Kounis / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Anatol J Cardiol Año: 2022 Tipo del documento: Article Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google